The early recognition and treatment of amyloidosis in order to minimise the effects of decline in health. Our focus is therefore on the improvement of diagnosis and the treatment of patients with amyloidosis. In addition, we offer information to patients, physicians and other individuals involved.
Who we are
The Groningen Amyloidosis Center of Expertise is a collaboration of various disciplines at the University Medical Center Groningen, engaged in diagnosis and treatment of systemic and localised amyloidosis. The department of Internal Medicine has a coordinating role.
|The International Society of Amyloidosis (ISA) has given recommendations for the management of amyloidosis patients during the COVID-19 pandemic||View the english version here|
|Amyloïdose Nederland (SAN)||You can find information about patient days here|
|Expertisenetwerk Amyloïdose||December 2019 on-line|
|2e Multidisciplinary Symposium Systemic Amyloidosis: How does it work in practice?||When:||November 12, 2020 from 9.15 am to 4 pm||Where:||InnStyle in Maarssen, fully in accordance with COVID-19 guidelines
If you prefer to follow the symposium online, you can choose for an online ticket
|For whom:||Hematologists, cardiologists, pathologists, nephrologists, neurologists, MDL doctors, rheumatologists, clinical geneticists and chemists, laboratory specialists, immunologists, nuclear physicians, radiologists, ophthalmologists in the Netherlands and Belgium and doctors in training for one of these specialties||For information and registration see:||DOEN congressen en evenementen|